Graham Holdings Co Dossier - Source-backed chat

Graham Holdings Co

GHCNYSE

SectorIndustrials

IndustryConglomerates

Beta (adjusted)0.82

Intrinsic Value $1,933.41median of 6 methods · middle span $909-$2,437based on filings through 30 Jun 2026

Market Price $1,151.29Price as of 1 Oct 2026

Significantly undervaluedIntrinsic value is 68% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

marker beyond scale (+68%)

Data confidence Sign in to view data confidence

Market Cap $4.9B

Enterprise Value $5.6B

Shares Outstanding 4.3M diluted

Moat Rating None

Next Earnings Date28 Oct 2026

Last ex-dividend16 Jul 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Graham Holdings Company (GHC) represents a classic sum-of-the-parts discount opportunity. As a highly decentralized conglomerate, its core education business (Kaplan) and robust healthcare services segment continue to drive solid organic growth, while its legacy television broadcasting and manufacturing assets provide stable cash generation. The stock trades at a significant discount to its estimated intrinsic value (often calculated at over 50% below DCF fair value estimates). With a strong balance sheet, active share buybacks, and proactive portfolio optimization—such as the sale of Kaplan Languages Group and the acquisition of Covenant Home Health—management is actively taking steps to unlock shareholder value.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets1 analysts · as of 18 Aug 2026

Low · most bearish analyst$990.00

Mean target$990.00

High · most bullish analyst$990.00

Street targets sit below today's price; our intrinsic value sits above it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$990.0015%

Persistent margin compression in the healthcare segment due to unfavorable regulatory rate changes, combined with a prolonged soft advertising environment affecting the television broadcasting division. Kaplan faces increased competition in professional training and test prep, leading to slower enrollment growth.

Base CaseCentral scenario

$990.0060%

Matches the consensus mean

The company continues its steady operational execution across its decentralized segments. Kaplan maintains mid-single-digit revenue growth, and the healthcare segment successfully integrates regional acquisitions to offset Medicare rate pressures. Management continues its disciplined capital allocation, utilizing robust operating cash flows to buy back shares at a steady pace, gradually narrowing the discount to intrinsic value.

Bull CaseUpside scenario

$990.0025%

A complete spin-off or strategic sale of Kaplan or the television broadcasting division occurs, eliminating the conglomerate discount. Kaplan's digital expansion and workforce readiness solutions accelerate, driving segment margins higher. Strong political ad spending in late 2026 boosts the broadcasting segment's profitability beyond expectations.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Significant sum-of-the-parts discount, with shares trading well below estimated intrinsic value.
Kaplan's strong brand equity and leadership in test prep, professional credentials, and workforce readiness.
Disciplined capital allocation history, characterized by consistent share repurchases and opportunistic acquisitions.
Strong balance sheet with substantial cash reserves providing defensive resilience.

Key Investment Risks

Conglomerate discount may persist indefinitely without a major structural catalyst (e.g., spin-off).
Regulatory risks in the healthcare segment, particularly regarding Medicare and Medicaid reimbursement rates.
Cyclical sensitivity of television broadcasting advertising revenues.
Decentralized structure limits operational synergies across business units.

Thesis Invalidation Triggers

A material decline in Kaplan's student enrollment or professional training demand.
Unfavorable regulatory changes that severely impact the profitability of the healthcare services segment.
Management shifting away from disciplined share buybacks toward value-destructive, large-scale acquisitions.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.